Antimicrobial susceptibility of 471 enterococcal strains responsible for infections at 101 French hospitals

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 18, Issue 11, 1999, Pages 836-838

  Pangon, B ^a   Pina, P ^d   Gazagne, L ^b   Chauvel, M ^c   Godard, T ^d   Courvalin, P ^c   Allouch, P ^d  

^a CENTRE HOSPITALIER DE VERSAILLES   (France)

^b Centre Hospitalier de Perpignan   (France)

^c INSTITUT PASTEUR   (France)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; GENTAMICIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; ENTEROCOCCUS; FRANCE; HUMAN; PHENOTYPE; PRIORITY JOURNAL;

EID: 0032761754     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050414     Document Type: Article

References (13)

1. Leclercq R, Derlot E, Duval J, Courvalin P: Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. New England Journal of Medicine (1988) 319:157-161
2. Uttley AH, Collins CH, Naidoo J, George RC: Vancomycin-resistant enterococci. Lancet (1988) 1:57-58
3. Arthur M, Reynolds P, Courvalin P: Glycopeptide resistance in enterococci. Trends in Microbiology (1996) 4:401-407
4. Conseil Supérieur d'Hygiène Publique de France: 100 recommandations pour la surveillance et la prévention des infections nosocomiales. Bulletin Epidémiologique Hebdomadaire. (1999) numéro spécial: 19-24
5. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. American Journal of Infection Control (1988) 16:128-140
6. Report of the Comité de l'Antibiogramme de la Société Française de Microbiologie. Technical recommendations for in vitro susceptibility testing. Clinical Microbiology and Infection (1996) 2, Supplement 1:11-25
7. Dukta-Malen S, Evers S, Courvalin P: Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci using polymerase chain reaction. Journal of Clinical Microbiology (1995) 33:24-27
8. Perlada DE, Smulian AG, Cushion MT: Molecular epidemiology and antibiotic susceptibility of enterococci in Cincinnati, Ohio: a prospective citywide survey. Journal of Clinical Microbiology (1997) 35:2342-2347
9. Caballero-Granado FJ, Cisneros JM, Luque R, Torres-Tortosa M, Gamboa F, Diez F, Villanueva JL, Perez-Cano R, Pasquau J, Merino D, Menchero A, Mora D, Lopez-Ruz MA, Vergara A, for the grupo Andaluzparaestudio de las Enfermedades Infecciosas: Comparative study of bacteremias caused by Enterococcus spp. with and without high-level resistance to gentamicin. Journal of Clinical Microbiology (1998) 36:520-525
10. Pfaller MA, Jones RN, Doern GV, Kugler K, and the SENTRY participants group: Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrobial Agents and Chemotherapy (1998) 42:1762-1770
11. Hirakata Y, Yamaguchi T, Izumikawa K, Matsuda J, Tomono K, Kaku M, Koga H, Yamada Y, Kohno S, Kamihira S: In vitro susceptibility studies and detection of vancomycin resistance genes in clinical isolates of enterococci in Nagasaki, Japan. Epidemiology and Infection (1997) 119:175-181
12. Felmingham D, Brown DF, Soussy CJ: European glycopeptide susceptibility survey of gram positive bacteria for 1995. European Glycopeptide Resistance Survey Group. Diagnostic Microbiology and Infectious Disease (1998) 31:563-571
13. Toye B, Shymanski J, Bobrowska M, Woods W, Ramotar K: Clinical and epidemiological significance of enterococci intrinsically resistant to vancomycin (possessing the vanC genotype). Journal of Clinical Microbiology (1997) 35:3166-3170